Fr901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243. Ii. In Vitro and In Vivo Activities

Fujie, A.; Iwamoto, T.; Muramatsu, H.; Okudaira, T.; Sato, I.; Furuta, T.; Tsurumi, Y.; Hori, Y.; Hino, M.; Hashimoto, S.; Okuhara, M.

The Journal of Antibiotics 53(9): 920-927

2000


DOI: 10.7164/antibiotics.53.920
Accession: 068516903

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
FR901469 is a water-soluble macrocyclic lipopeptidolactone (C71H116N14O23) that has inhibitory activity against 1,3-beta-glucan synthase and exhibits in vitro and in vivo antifungal activity against both Candida albicans and Aspergillus fumigatus. The MICs of FR901469 against Candida albicans FP633 and Aspergillus fumigatus FP1305 in a micro-broth dilution test were 0.63 and 0.16 microg/ml, respectively. FR901469 showed excellent efficacy by subcutaneous injection against both Candida albicans and Aspergillus fumigatus in a murine systemic infection mode, with ED50s of 0.32 and 0.2 mg/kg, respectively. This compound also showed potent anti-Pneumocystis activity in the nude mice model with experimental Pneumocystis pneumonia. The hemolytic activity of FR901469 towards mouse red blood cells, is about 30-fold weaker than that of amphotericin B.